Gene Query: RNF31

Dataset Description Geneva Score
Genome wide expression change in LCC2 and MCF-7 cells 43.09
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 31.22
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 31.22
Cellular response to hepatitis E virus (HEV) infection 21.4
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 19.22
H1609088 Human RNA-Sequencing 17.51
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 16.89
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 15.21
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 14.69
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 14.69
Genome wide expression change by RNF168 knocking down in NEC cells 12.87
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 12.44
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 11.46
BAF controls genome accessibility 11.1
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 10.6
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 10.26
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 10.06
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 10.06
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 9.92
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 9.78
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 9.78
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 9.76
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 9.5
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 9.27
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 9.16
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 9.05
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 9.05
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 9.04
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 9.0
UBC9 knockdown in bladder cancer T24 cell lines 8.93
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 8.8
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 8.73
Transcriptional responses of human insulinoma cells to acute cytokine exposure 8.66
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 8.55
Transcriptome analysis of SKI knock-out in HL60 cells 8.55
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 8.33
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 8.31
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 8.27
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.19
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 8.01
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.85
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 7.69
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 7.6
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 7.51
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 7.45
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 7.2
Macrophage Ad5f35 M2 Challenge 7.16
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 7.09
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 6.92
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 6.92
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.87
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 6.84
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 6.65
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 6.53
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 6.5
RNAseq analysis of ESRP regulated splicing events in prostate cancer 6.47
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 6.43
Searching for target genes of miR-508/509/506/514 in HCT116 cells 6.31
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 6.3
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 6.29
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 6.23
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 6.23
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.22
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 6.15
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 6.13
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 6.13
Stem and effector CD8 T-cells from human cancers 6.1
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 6.1
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 6.03
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 6.03
Overexpression of NFIB and YBX1 in MCF-7 cells 6.01
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 5.91
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.8
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 5.8
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 5.63
Tumor exosome integrins determine organotropic metastasis 5.62
snRNAs as regulators of alternative splicing 5.52
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 5.51
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 5.44
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 5.43
RNA-Seq analysis of breast cancer cells after shikonin treatment 5.35
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 5.32
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 5.24
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.15
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.14
Differetially expressed genes after hTR overexpression in U2OS cells 5.08
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 5.08
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 5.07
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 5.03
Intrahepatic MAIT cell gene expression revealed by RNA-seq 4.99
Disruption of the exocyst induces podocyte loss and dysfunction 4.98
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 4.98
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 4.98
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 4.95
RNA-seq of naive and primed ES cells 4.89
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.87
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.87
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 4.86
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 4.85
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 4.8
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 4.8
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 4.77
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 4.75
RNA-seq differential expression studies: more sequence, or more replication? 4.73
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 4.71
Pharmacologic inhibition of STAT5 in AML 4.64
Paxillin regulates genomic networks in prostate cancer [PC3] 4.63
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 4.61
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.61
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 4.59
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 4.59
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 4.56
NKX2.2 4.54
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 4.54
DART-seq: an antibody-free method for global m6A detection 4.51
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 4.5
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 4.49
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.46
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 4.45
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 4.45
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 4.44
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 4.44
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.43
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 4.42
Expression data from miR340 overexpressing human A549 cells 4.39
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.39
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 4.38
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 4.38
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.36
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 4.36
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 4.34
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 4.32
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 4.31
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 4.3
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 4.3
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 4.29
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 4.29
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.24
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 4.22
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 4.16
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 4.15
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 4.14
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 4.14
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 4.13
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 4.11
Human neutrophil genome during PMA- and E. coli encounter-induced activation 4.11
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 4.1
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 4.07
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 4.07
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 4.07
Modulation of nonsense-mediated decay by rapamycin 4.04
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 4.02
R430: A potent inbibitor of DNA and RNA viruses 4.01
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.01
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.01
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.0
Gene expression regulated by CSA and CSB in neuroblastoma cell line 4.0
Single-nucleotide-resolution mapping of HBV promoters using CAGE 3.97
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 3.96
CD95/Fas ligand mRNA is toxic to cells 3.96
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 3.96
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 3.96
hTERT promotes cell adhesion and migration independent of telomerase activity 3.95
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 3.93
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.93
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.93
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 3.87
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 3.86
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 3.86
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 3.85
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.84
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.82
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 3.8
RNAseq Study in CC-671 Treated Cal-51 Cells 3.79
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 3.79
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 3.77
RNA-seq of human aneuploid cell lines with Trisomy 21 3.76
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.75
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 3.75
LncRNA expression profiling of ischemic stroke patients 3.72
Primary human trophoblast from term placenta 3.72
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 3.71
Evolution of a transcriptional regulator from a transmembrane nucleoporin 3.7
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 3.69
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 3.68
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.67
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 3.64
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 3.62
Macrophage Ad5f35 PhenoMap 3.59
Landscape and variation of RNA secondary structure across the human transcriptome 3.57
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 3.57
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.54
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 3.54
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 3.51
Expression profiling of MCF-7 cells with treatment of TCDD 3.51
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.51
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 3.5
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 3.5
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 3.48
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 3.46
The effect of insulin on mRNA transcription of human pluripotent stem cells 3.43
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 3.43
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 3.39
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 3.38
Regulation of hypoxia-inducible factor activity by ZMYND8 3.37
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.37
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.33
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 3.33
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.33
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.32
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 3.32
High-throughput sequencing of pluripotent cells 3.28
Transcriptional changes in lymphoma cells induced by LSD1 depletion 3.27
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 3.27
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 3.26
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 3.25
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 3.2
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 3.2
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 3.19
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 3.18
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 3.18
PRDM1 inhibits proliferation of human colon cancer organoids 3.18
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.18
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 3.13
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 3.13
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 3.1
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 3.1
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 3.09
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.09
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.09
High-Throughput Kinetic Analysis of Fractional Killing 3.08
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 3.07
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 3.07
The effect of Abl kinases on non-small cell carcinoma global transcriptome 3.06
Silencing SPIB in attached and floating state of H1703 lung cancer cells 3.02
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 3.0
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 2.96
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 2.96
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 2.95
Intron retention induced by microsatellite expansions as a disease biomarker. 2.95
Transciptomic profiling of human fetal lung samples 2.94
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.88
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 2.84
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 2.81
RNA Seq of HMVEC under hypoxia 2.81
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.77
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 2.77
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 2.76
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 2.74
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 2.73
Gene expression profiling of leukemia cells following asparagine depletion 2.72
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 2.67
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 2.66
Exploring ILF2 regulatory genes by next-generation sequencing 2.65
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 2.64
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.63
RNA-Seq and expression data from human adipose tissue 2.63
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.62
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.61
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 2.61
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.6
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 2.59
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.55
PTHrP overexpression in MCF7 cells 2.49
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 2.46
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 2.45
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 2.44
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.43
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 2.42
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 2.42
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 2.41
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 2.41
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.41
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.4
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 2.37
Effect of drugs on transcriptomic profiles 2.36
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.27
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.23
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 2.23
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.21
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.19
RNAseq of cell lines with knocked in ESR1 mutations 2.19
Gene expression in GBM with Cav3.2 inhibition 2.15
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 2.1
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.1
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.1
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.1
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 2.09
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 2.06
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 2.06
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.03
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.03
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 2.02
Glioblastoma stem cells infected by ZIKA virus 2.01
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.98
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.96
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.96
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 1.94
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 1.94
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 1.94
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 1.94
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 1.93
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 1.93
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.88
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.87
Molecular Criteria for Defining the Naive Human Pluripotent State 1.85
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 1.85
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 1.81
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.8
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 1.8
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 1.8
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.78
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.75
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.74
X-Ray induced DNA-Hydroxymethylation changes 1.73
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 1.72
Effect of nuclear IL-33 on gene expression 1.72
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 1.71
IRF1 regulates IFN dependent and independent gene expression 1.7
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 1.69
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.67
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.67
Functional significance of the HIV-1 Tat signature amino acid residues 1.65
Iron response of HepG2 cells 1.65
Cajal bodies are linked to genome conformation [RNA-Seq] 1.64
Cajal bodies are linked to genome conformation 1.64
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.63
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.62
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.62
DRB/GRO-Seq -/+ UV 1.61
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.57
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.53
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.53
Oncogenic roles of ARID5B in T-ALL 1.53
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.53
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.51
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 1.5
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 1.5
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 1.5
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.5
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 1.5
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.48
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.47
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.47
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.46
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.45
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.42
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.4
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.4
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.39
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.37
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 1.36
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.34
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.34
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.34
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 1.32
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 1.32
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.28
Fusion discovery in breast cancer cell line 1.28
Downregulation of LATS kinases alters p53 to promote cell migration 1.27
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.26
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.25
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.25
Investigate A2M treatment on human prostate cancer xenograft in mice 1.23
Investigate A2M treatment on human prostate cancer and mouse liver 1.23
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 1.23
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.23
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.23
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.21
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.21
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 1.21
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.11
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 1.1
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.1
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.1
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.07
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.07
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.07
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.06
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.06
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.06
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 1.04
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.03
Transcriptome of Stabilin-1 siRNA transfected human monocytes 1.01
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.0
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.0
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.0
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 0.99
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.98
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.98
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.93
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.93
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.92
BASP1 modifies the Tamoxifen response 0.92
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.9
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.89
Targeted enhancer activation by a subunit of the integrator complex 0.89
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.88
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.87
Gene expression analysis upon mtDNA depletion 0.87
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.87
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.86
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.85
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.85
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.85
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.85
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.83
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.83
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.83
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.83
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 0.82
MCF-7 as a model for functional analysis of breast cancer risk variants 0.79
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.79
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 0.76
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.7
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 0.69
miRNAs affected by antagomiR-17 treatment 0.67
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.67
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.67
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.66
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.62
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 0.61
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 0.61
Tpl-2 and MEK small molecule inhibitors 0.61
Tpl-2 small molecule project 0.61
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 0.61
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.6
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.59
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.56
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.55
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.54
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 0.54
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 0.54
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.52
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.52
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 0.52
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.51
naive T cell heterogeneity after neonatal thymectomy 0.5
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.48
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.48
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.47
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.45
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.44
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.44
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.41
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.41
Discovering human diabetes-risk gene function with genetics and physiological assays 0.41
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.38
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.37
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.36
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.35
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.34
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.34
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.34
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.34
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.34
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.33
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.32
Transcriptome of activated human and mouse MAIT cells 0.32
Energy Metabolism during Anchorage-Independence 0.31
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.3
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.3
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.3
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.3
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.29
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.28
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.24
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.21
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.21
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.21
The pioneer factor CEBPA modulates vitamin D signaling 0.21
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.21
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 0.21
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.19
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.16
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.16
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.15
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.15
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.15
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.13
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.13
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.13
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.13
The role of m6A/m-RNA methylation in stress response regulation 0.13
Polarized B -cell functions 0.13
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.11
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.1
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.09
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.08
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.08
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.08
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.07
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.04
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.03
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.03
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 0.02
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.02
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.02
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.02
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation